在临床前阿尔茨海默氏病的特定亚核中的杏仁体缩
Yasmine Salman1, Thomas Gérard1,2, Lara Huyghe1
1Louvain Aging Brain Lab, Institute of Neuroscience, UCLouvain, Brussels, Belgium.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|September 10, 2024
概括
特定的杏仁核亚核缩,而不是全球体积,表明早期阿尔茨海默氏症 (AD) tau病理. 这一发现可能有助于识别患有临床前AD进展风险的个体.
科学领域:
- 神经成像是一种神经成像.
- 神经病理学神经病理学
- 生物标志物发现发现
背景情况:
- 磁共振成像 (MRI) 能够进行详细的中叶 (MTL) 亚结构分析,这对于识别临床前阿尔茨海默病 (AD) 生物标志物至关重要.
- 研究海马子领域和杏仁核子提供了对早期AD病理学的见解.
研究的目的:
- 在非痴呆个体中识别与病理相关的特定MTL亚结构.
- 调查杏仁核亚核缩作为临床前AD早期生物标志物的潜力.
主要方法:
- 利用MRI细分来分析来自阿尔茨海默病神经成像计划 (ADNI-3) 的581名非痴呆症患者的MTL亚体结构.
- 相关联的MTL亚体体积与阳子辐射断层扫描 (PET) 信号.
- 在使用视觉Braak的分期和临床诊断的单独队列 (UCLouvain,110人) 中确认了这一发现.
主要成果:
- 四个桃体亚核 (皮质,中心,中间,辅助基底) 在粉样蛋白β-阳性 (Aβ+) 临床正常 (CN) 个体中与tau显著相关.
- 全球杏仁体和海马体积与tau没有关联.
- 在这些特定的桃体亚核中观察到的缩是在早期布拉克阶段 (I-II) 和Aβ+ CN状态的个体中观察到的.
结论:
- 特定桃体亚核中的缩,而不是全球体积,在临床前的AD中作为时性陶病的潜在标志物.
- 这种有针对性的测量可以帮助识别具有更高AD进展风险的个体.
- 杏仁体缩在临床前阿尔茨海默氏症中是异质的,病理特别影响某些亚核.
关键词:
在AV1451中,AV1451是第一个.阿尔茨海默氏症的疾病是阿尔茨海默氏症.MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MMK6240MK6240MK6240MK6240MMK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240MK6240M杏仁体的亚核是什么意思生物标志物生物标志物佛罗里达奎因图奎因图一个漂亮的吸血鬼.在临床前的AD.结构磁共振成像 结构磁共振成像病症是一种病症.陶正子辐射断层扫描.更多相关视频
相关概念视频
Role of Amygdala in Memory
185
The amygdala is a small, almond-shaped structure responsible for processing and storing memories, particularly those linked to emotions like fear and stress. It plays an essential role in the brain's response to emotionally significant events and often enhances memory formation by triggering stress hormone release. The amygdala is vital for encoding and retrieving memories associated with fear or stress, a process that is adaptive by helping organisms avoid dangerous situations.
One of the...
One of the...
185
Functional Brain Systems: Limbic System
2.4K
The limbic system, often called the "emotional brain," is a complex set of structures located deep within the brain. The intricate network of the limbic system supports a wide range of psychological functions, from emotional regulation to memory formation and sensory processing. This functional brain region encompasses specific parts of the diencephalon and the cerebrum, integrating the higher mental functions of the cerebral cortex with the primitive emotional responses of the deep brain...
2.4K
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170


